147 related articles for article (PubMed ID: 19286307)
1. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model.
Bernardi A; Braganhol E; Jäger E; Figueiró F; Edelweiss MI; Pohlmann AR; Guterres SS; Battastini AM
Cancer Lett; 2009 Aug; 281(1):53-63. PubMed ID: 19286307
[TBL] [Abstract][Full Text] [Related]
2. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study.
Bernardi A; Frozza RL; Jäger E; Figueiró F; Bavaresco L; Salbego C; Pohlmann AR; Guterres SS; Battastini AM
Eur J Pharmacol; 2008 May; 586(1-3):24-34. PubMed ID: 18371953
[TBL] [Abstract][Full Text] [Related]
3. Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme.
da Silveira EF; Chassot JM; Teixeira FC; Azambuja JH; Debom G; Beira FT; Del Pino FA; Lourenço A; Horn AP; Cruz L; Spanevello RM; Braganhol E
Invest New Drugs; 2013 Dec; 31(6):1424-35. PubMed ID: 24072435
[TBL] [Abstract][Full Text] [Related]
4. The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways.
Bernardi A; Frozza RL; Hoppe JB; Salbego C; Pohlmann AR; Battastini AM; Guterres SS
Int J Nanomedicine; 2013; 8():711-28. PubMed ID: 23440594
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth.
Figueiró F; Bernardi A; Frozza RL; Terroso T; Zanotto-Filho A; Jandrey EH; Moreira JC; Salbego CG; Edelweiss MI; Pohlmann AR; Guterres SS; Battastini AM
J Biomed Nanotechnol; 2013 Mar; 9(3):516-26. PubMed ID: 23621009
[TBL] [Abstract][Full Text] [Related]
6. 2-(2-Methoxyphenyl)-3-((Piperidin-1-yl)ethyl)thiazolidin-4-One-Loaded Polymeric Nanocapsules: In Vitro Antiglioma Activity and In Vivo Toxicity Evaluation.
da Silveira EF; Ferreira LM; Gehrcke M; Cruz L; Pedra NS; Ramos PT; Bona NP; Soares MSP; Rodrigues R; Spanevello RM; Cunico W; Stefanello FM; Azambuja JH; Horn AP; Braganhol E
Cell Mol Neurobiol; 2019 Aug; 39(6):783-797. PubMed ID: 31115733
[TBL] [Abstract][Full Text] [Related]
7. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
Zanotto-Filho A; Coradini K; Braganhol E; Schröder R; de Oliveira CM; Simões-Pires A; Battastini AM; Pohlmann AR; Guterres SS; Forcelini CM; Beck RC; Moreira JC
Eur J Pharm Biopharm; 2013 Feb; 83(2):156-67. PubMed ID: 23219677
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model.
Zhang YH; Yue ZJ; Zhang H; Tang GS; Wang Y; Liu JM
Eur J Pharm Biopharm; 2010 Nov; 76(3):371-5. PubMed ID: 20816959
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of recidive malignant gliomas with temozolomide].
Sipos L; Vitanovics D; Afra D
Orv Hetil; 2002 May; 143(21):1201-4. PubMed ID: 12073541
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D
Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
[TBL] [Abstract][Full Text] [Related]
12. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.
Morrone FB; Oliveira DL; Gamermann P; Stella J; Wofchuk S; Wink MR; Meurer L; Edelweiss MI; Lenz G; Battastini AM
BMC Cancer; 2006 Sep; 6():226. PubMed ID: 16995949
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
Haas-Kogan DA; Prados MD; Tihan T; Eberhard DA; Jelluma N; Arvold ND; Baumber R; Lamborn KR; Kapadia A; Malec M; Berger MS; Stokoe D
J Natl Cancer Inst; 2005 Jun; 97(12):880-7. PubMed ID: 15956649
[TBL] [Abstract][Full Text] [Related]
14. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.
Allard E; Passirani C; Garcion E; Pigeon P; Vessières A; Jaouen G; Benoit JP
J Control Release; 2008 Sep; 130(2):146-53. PubMed ID: 18582507
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
Figueiró F; de Oliveira CP; Rockenbach L; Mendes FB; Bergamin LS; Jandrey EH; Edelweiss MI; Guterres SS; Pohlmann AR; Battastini AM
J Biomed Nanotechnol; 2015 Oct; 11(10):1808-18. PubMed ID: 26502643
[TBL] [Abstract][Full Text] [Related]
18. [Morphologic findings and biologic behavior in the high grade glioma--a postmortem study of 22 cases].
Ogashiwa M; Maeda T; Yokoyama H; Takeuchi K; Akai K
Gan No Rinsho; 1989 Sep; 35(11):1297-307. PubMed ID: 2478732
[TBL] [Abstract][Full Text] [Related]
19. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.
Kim JT; Kim JS; Ko KW; Kong DS; Kang CM; Kim MH; Son MJ; Song HS; Shin HJ; Lee DS; Eoh W; Nam DH
Oncol Rep; 2006 Jul; 16(1):33-9. PubMed ID: 16786120
[TBL] [Abstract][Full Text] [Related]
20. Novel anti-angiogenic therapies for malignant gliomas.
Norden AD; Drappatz J; Wen PY
Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
